ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Human and Mouse Treg Use Lymphotoxin for Migration Across Lymphatic Endothelium.

C. Brinkman,1 K. Hippen,2 B. Blazar,2 J. Bromberg.1

1University of Maryland, Baltimore, MD
2Univerity of Minnesota, Minneapolis, MN.

Meeting: 2016 American Transplant Congress

Abstract number: 253

Keywords: Endothelial cells, T cells

Session Information

Date: Monday, June 13, 2016

Session Name: Concurrent Session: Regulatory T Cells: Animal Models

Session Time: 2:30pm-4:00pm

 Presentation Time: 3:30pm-3:42pm

Location: Room 309

Related Abstracts
  • Lymphotoxin Controls Treg Interactions With Lymphatic Endothelial Cells and Interstitial Migration In Vivo
  • Sphingosine 1-Phosphate (S1P) Receptors Differentially Regulate Murine and Human CD4 T Cell Migration Across Lymphatic Endothelium.

Introduction: Lymphotoxin (LT) directs lymphoid organ structure, and LTβ receptor (LTβR) is involved in leukocyte migration into lymph nodes (LN) and thymocyte migration. We previously showed LT was required for murine Treg to prolong islet allograft survival, and for Treg migration from tissues into afferent lymphatics by regulating interactions with lymphatic endothelial cells (LEC). We hypothesized that human Treg would use LT to regulate their interaction and migration through human LEC.

Methods: Murine Treg were generated from Foxp3GFP mice, and flow-sorted for CD25 and Foxp3GFP. Naïve human T cells were flow-sorted from peripheral blood, and effectors and induced Treg (iTreg) were stimulated with anti-CD3, IL-2 and antigen presenting cells (APCs). iTreg received TGFβ1 and rapamycin. Thymus-derived tTreg were isolated from umbilical cord blood and expanded with anti-CD3, IL-2 and APCs. T cells were used in transmigration assays across primary mouse and human skin LEC and the murine LEC line SVEC4-10. For footpad assays tTreg were labeled with CFSE, injected into footpads, and analyzed in draining popliteal LN 12h later. LTβR fusion protein (LTβRIg) was used to block Treg LTαβ.

Results: Consistent with our previous results using mouse T cells and LEC, human Treg but not non-Treg CD4 T cell migration across human skin LEC was inhibited by LT blockade. We extended our mechanistic understanding of the action of LT. Murine Treg migration across SVEC4-10 and primary mouse LEC layers was specifically inhibited by blocking LTαβ-LTβR interactions, blocking VCAM-1, or inhibiting the non-canonical NFκB pathway. Migration of other T cell subsets was not inhibited by any of these agents. Inhibitory effects of these treatments were not additive, suggesting they were part of the same pathway. Inhibitory effects were further enhanced by simulating lymphatic fluid flow across the LEC. Finally, LT and VCAM-1 blockade also inhibited Treg but not non-Treg CD4+ T cell migration in vivo from footpad to draining LN. .

Conclusions: Both human and murine Treg but not non-Treg rely on cell surface LTαβ to stimulate LTβR on lymphatic endothelium for lymphatic migration. This mechanism involves VCAM-1 and the non-canonical NFκB pathway and operates under both static conditions and fluid flow. As lymphatic flow is modulated during inflammation this may also result in different sensitivity to this pathway depending upon the phase of the inflammatory response.

CITATION INFORMATION: Brinkman C, Hippen K, Blazar B, Bromberg J. Human and Mouse Treg Use Lymphotoxin for Migration Across Lymphatic Endothelium. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Brinkman C, Hippen K, Blazar B, Bromberg J. Human and Mouse Treg Use Lymphotoxin for Migration Across Lymphatic Endothelium. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/human-and-mouse-treg-use-lymphotoxin-for-migration-across-lymphatic-endothelium/. Accessed March 6, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Role of Mitochondria, Metabolism and Inflammation: Pathways Influencing Short Term Outcomes Post-Renal Transplantation
    • Factors Influencing Creatinine Rise Following Donor Nephrectomy

    Visit Our Partner Sites

    American Transplant Congress (ATC)

    Visit the official site for the American Transplant Congress »

    American Journal of Transplantation

    The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

    American Society of Transplantation (AST)

    An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

    American Society of Transplant Surgeons (ASTS)

    The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

    Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

    Privacy Policy

    loading Cancel
    Post was not sent - check your email addresses!
    Email check failed, please try again
    Sorry, your blog cannot share posts by email.
    This site uses cookies: Find out more.